List of works - Françoise Imbert-Bismut

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

scientific article

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

scientific article

A reference material for traceability of aspartate aminotransferase (AST) results

scientific article published in January 2005

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

scientific article

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

scientific article

Assessment of liver fibrosis: noninvasive means

scientific article published on October 2008

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

scientific article published in September 2002

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

scientific article published in February 2005

Biomarkers of liver fibrosis

scientific article published on January 2008

Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

scientific article

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

scientific article

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

scientific article

FibroMAX: towards a new universal biomarker of liver disease?

scientific article published on September 2007

Harmonization of liver enzyme results: calibration for aminotransferases and gamma glutamyltransferase

scientific article published in September 2004

Hemolysis indexes for biochemical tests and immunoassays on Roche analyzers: determination of allowable interference limits according to different calculation methods

scientific article published on 22 January 2015

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)

scientific article

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

scientific article

Meta-analyses of FibroTest diagnostic value in chronic liver disease

scientific article

Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.

scientific article published in October 2007

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

scientific article

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

scientific article

Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study

scientific article

Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up

scientific article published on 6 August 2013

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

scientific article published in March 2003

The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption

scientific article

The elusiveness of "normal" ALT in fatty liver

scientific article published in April 2004

The use of enzyme results for liver fibrosis evaluation necessitates standardization

scientific article published in March 2008

Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".

scientific article published on 9 June 2014

List of works by Françoise Imbert-Bismut

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

A reference material for traceability of aspartate aminotransferase (AST) results

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

Assessment of liver fibrosis: noninvasive means

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

Biomarkers of liver fibrosis

Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

FibroMAX: towards a new universal biomarker of liver disease?

Harmonization of liver enzyme results: calibration for aminotransferases and gamma glutamyltransferase

Hemolysis indexes for biochemical tests and immunoassays on Roche analyzers: determination of allowable interference limits according to different calculation methods

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

Meta-analyses of FibroTest diagnostic value in chronic liver disease

Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study

Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption

The elusiveness of "normal" ALT in fatty liver

The use of enzyme results for liver fibrosis evaluation necessitates standardization

Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".